Are These 3 Cheap Dividend Stocks With High Yields Too Good to Be True?
https://www.fool.com/investing/2023/12/14/are-these-3-cheap-dividend-stocks-with-high-yields/?source=iedfolrf0000001
Dec 14, 2023 - The highest-yielding stock on this list pays 7.7%.
0
Pfizer Slashed Its Guidance, but Is It Still a Smart Long-Term Buy?
https://www.fool.com/investing/2023/12/18/pfizer-slashed-its-guidance-but-is-it-still-a-buy/?source=iedfolrf0000001
Dec 18, 2023 - It's no secret that the next couple of years will be slow.
0
Are Investors Overreacting to Pfizer's Underwhelming Forecast for 2024?
https://www.fool.com/investing/2023/12/23/are-investors-overreacting-to-pfizer-underwhelming/?source=iedfolrf0000001
Dec 23, 2023 - Is Pfizer stock a bargain buy?
0
Got $5,000? Buy and Hold These 3 Value Stocks for Years
https://www.fool.com/investing/2023/12/30/got-5000-buy-and-hold-these-3-value-stocks-for-yea/?source=iedfolrf0000001
Dec 30, 2023 - Sometimes it pays for investors to take a step back and look at the (much) bigger, longer-term picture.
0
10 High-Yield Dividend Stocks for Huge Amounts of Income
https://www.fool.com/investing/2024/01/16/10-high-yield-dividend-stocks-for-huge-amounts-of/?source=iedfolrf0000001
Jan 16, 2024 - All 10 of these dividend stocks have yields above 4%.
0
4 Magnificent Stocks I'm Done Waiting on a Dip for in 2024 -- but I'm Not Buying Them Hand Over Fist, Either
https://www.fool.com/investing/2024/01/20/4-magnificent-stocks-im-done-waiting-on-a-dip-for/?source=iedfolrf0000001
Jan 20, 2024 - These stocks never seem to go on sale. Here's why I'm buying them anyway.
0
The Bull Market Left These 3 Stocks Behind, but They're Buys Right Now
https://www.fool.com/investing/2024/02/04/the-bull-market-left-these-3-stocks-behind-but-the/?source=iedfolrf0000001
Feb 04, 2024 - Sometimes, undervalued market laggards have what it takes to catch up over the long haul.
0
Have $2,000? 2 Magnificent Stocks Ready for a Bull Run
https://www.fool.com/investing/2024/03/10/have-2000-2-magnificent-stocks-ready-for-a-bull-ru/?source=iedfolrf0000001
Mar 10, 2024 - These stocks are trading down, but investors may be overlooking some important points.
0
Roche (RHHBY) to Acquire Obesity Drug Maker Carmot for $2.7B
https://www.zacks.com/stock/news/2193099/roche-rhhby-to-acquire-obesity-drug-maker-carmot-for-2-7b?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2193099
Dec 04, 2023 - Roche (RHHBY) aims to enter the promising and much-in-demand obesity drug market with the acquisition of Carmot Therapeutics, Inc. for $2.7 billion.
0
Pharma Stock Roundup: ABBV to Buy CERE, JNJ's 2024 View, LLY & NVS Get FDA Nod
https://www.zacks.com/stock/news/2195315/pharma-stock-roundup-abbv-to-buy-cere-jnj-s-2024-view-lly-nvs-get-fda-nod?cid=CS-ZC-FT-analyst_blog|stock_roundup-2195315
Dec 08, 2023 - AbbVie (ABBV) offers to acquire Cerevel Therapeutics for $8.7 billion. J&J (JNJ) announces sales and earnings growth expectations for 2024.
0